JMVNX
Price
$15.93
Change
+$0.17 (+1.08%)
Updated
Jan 30 closing price
Net Assets
1.39B
JVMSX
Price
$28.04
Change
+$0.25 (+0.90%)
Updated
Jan 30 closing price
Net Assets
23.09B
Ad is loading...

JMVNX vs JVMSX

Header iconJMVNX vs JVMSX Comparison
Open Charts JMVNX vs JVMSXBanner chart's image
JHFunds2 Mid Value NAV
Price$15.93
Change+$0.17 (+1.08%)
VolumeN/A
Net Assets1.39B
JHancock Disciplined Value Mid Cap R2
Price$28.04
Change+$0.25 (+0.90%)
VolumeN/A
Net Assets23.09B
JMVNX vs JVMSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JMVNX vs. JVMSX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMVNX is a StrongBuy and JVMSX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JVMSX has more cash in the bank: 23.1B vs. JMVNX (1.39B). JMVNX pays higher dividends than JVMSX: JMVNX (1.08) vs JVMSX (0.52). JMVNX was incepted earlier than JVMSX: JMVNX (16 years) vs JVMSX (13 years). JMVNX is a more actively managed with annual turnover of: 55.00 vs. JVMSX (41.00). JMVNX (0) and JVMSX (0) have matching initial minimum investment requirements. JVMSX annual gain was more profitable for investors over the last year : 4.08 vs. JMVNX (-0.56). JVMSX return over 5 years is better than : 29.59 vs. JMVNX (11.43).
JMVNXJVMSXJMVNX / JVMSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years13 years-
Gain YTD3.4803.65595%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.39B23.1B6%
Annual Yield % from dividends1.080.52208%
Returns for 1 year-0.564.08-14%
Returns for 3 years-12.013.78-317%
Returns for 5 years11.4329.5939%
Returns for 10 years10.4443.4424%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NTLA10.510.39
+3.85%
Intellia Therapeutics
GT9.230.16
+1.76%
Goodyear Tire & Rubber Company (The)
CTXR2.830.04
+1.43%
Citius Pharmaceuticals Inc
MTB201.981.62
+0.81%
M&T Bank Corp
ABEO5.470.02
+0.37%
Abeona Therapeutics